Shengxi Meng

1.2k total citations · 1 hit paper
29 papers, 919 citations indexed

About

Shengxi Meng is a scholar working on Complementary and alternative medicine, Neurology and Physiology. According to data from OpenAlex, Shengxi Meng has authored 29 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Complementary and alternative medicine, 10 papers in Neurology and 10 papers in Physiology. Recurrent topics in Shengxi Meng's work include Alzheimer's disease research and treatments (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Shengxi Meng is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). Shengxi Meng collaborates with scholars based in China and United States. Shengxi Meng's co-authors include Qin Feng, Jinghua Peng, Yiyang Hu, Jianmei Cao, Niu Tian, R. Davis Manning, Bing Wang, Wentao Li, Zhicheng Liu and Zhou Wang and has published in prestigious journals such as Neuroscience, RSC Advances and BioMed Research International.

In The Last Decade

Shengxi Meng

29 papers receiving 901 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Roles of Chlorogenic Acid on Regulating Glucose and Lipids Metabolism: A Review

2013 465 citations Shengxi Meng, Qin Feng et al. Evidence-based Complementary and Alternative Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shengxi Meng China	13	283	169	164	157	144	29	919
Koichi Misawa Japan	10	255 0.9×	126 0.7×	190 1.2×	162 1.0×	126 0.9×	16	737
Yogeeta O. Agrawal India	17	350 1.2×	226 1.3×	131 0.8×	138 0.9×	89 0.6×	53	1.3k
Muniruddin Ahmed Bangladesh	9	389 1.4×	126 0.7×	244 1.5×	169 1.1×	183 1.3×	10	1.1k
Siva Reddy Challa India	17	275 1.0×	106 0.6×	218 1.3×	141 0.9×	131 0.9×	73	1.1k
Adriano Cressoni Araújo Brazil	22	316 1.1×	151 0.9×	349 2.1×	146 0.9×	86 0.6×	77	1.3k
Yaoyao Jia South Korea	21	416 1.5×	162 1.0×	132 0.8×	83 0.5×	152 1.1×	29	1.0k
Parichat Prachaney Thailand	21	258 0.9×	213 1.3×	202 1.2×	148 0.9×	147 1.0×	54	1.4k
Fátima Husein Abdalla Brazil	18	212 0.7×	151 0.9×	194 1.2×	201 1.3×	79 0.5×	33	988
Jucimara Baldissarelli Brazil	19	177 0.6×	140 0.8×	164 1.0×	176 1.1×	95 0.7×	39	981
Eunjin Sohn South Korea	20	359 1.3×	230 1.4×	151 0.9×	131 0.8×	96 0.7×	73	1.2k

Countries citing papers authored by Shengxi Meng

Since Specialization

Citations

This map shows the geographic impact of Shengxi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengxi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengxi Meng more than expected).

Fields of papers citing papers by Shengxi Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengxi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengxi Meng. The network helps show where Shengxi Meng may publish in the future.

Co-authorship network of co-authors of Shengxi Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Shengxi Meng. A scholar is included among the top collaborators of Shengxi Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengxi Meng. Shengxi Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Jing, et al.. (2025). A carrier-free therapeutic eutectogel: construction, physical properties, and anti-bacterial ability. RSC Advances. 15(34). 27652–27660. 1 indexed citations

Zhu, Mengting, et al.. (2024). Combined Catalpol and Tetramethylpyrazine Promote Axonal Plasticity in Alzheimer’s Disease by Inducing Astrocytes to Secrete Exosomes Carrying CDK5 mRNA and Regulating STAT3 Phosphorylation. Molecular Neurobiology. 61(12). 10770–10791. 10 indexed citations

Guttentag, Susan H., Seunghyi Kook, Shengxi Meng, et al.. (2024). Mitochondrial Fragmentation as a Feature of Disrupted BLOC3 Function in Hermansky Pudlak Syndrome Type 1 (HPS1). A2524–A2524. 1 indexed citations

Li, Menghan, Jing Yuan, Shengxi Meng, et al.. (2023). Therapeutic deep eutectic solvents based on natural product matrine and caprylic acid: Physical properties, cytotoxicity and formation of surfactant free microemulsion. Journal of Drug Delivery Science and Technology. 90. 105177–105177. 7 indexed citations

Meng, Shengxi, et al.. (2023). Catalpol Mitigates Alzheimer's Disease Progression by Promoting the Expression of Neural Stem Cell Exosomes Released miR-138-5p. Neurotoxicity Research. 41(1). 41–56. 11 indexed citations

Meng, Shengxi, et al.. (2023). Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism. Frontiers in Endocrinology. 14. 956772–956772. 21 indexed citations

Meng, Shengxi, et al.. (2022). Metabolomics Deciphering the Potential Biomarkers of Hengqing I Prescription against Vascular Dementia. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 1 indexed citations

Meng, Shengxi, et al.. (2022). Effects of Catalpol on Alzheimer’s Disease and Its Mechanisms. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 16 indexed citations

Meng, Shengxi, et al.. (2022). Gastrodin and Vascular Dementia: Advances and Current Perspectives. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 13 indexed citations

10.

Meng, Shengxi, et al.. (2022). Multiple Roles of Paeoniflorin in Alzheimer’s Disease. Evidence-based Complementary and Alternative Medicine. 2022. 1–11. 5 indexed citations

11.

Meng, Shengxi, et al.. (2022). Therapeutic Effects and Metabolic Spectrum of Traditional Chinese Medicine Hengqing II Prescription on Alzheimer’s Disease. Evidence-based Complementary and Alternative Medicine. 2022. 1–12. 2 indexed citations

12.

Meng, Shengxi, et al.. (2022). Potential cellular endocrinology mechanisms underlying the effects of Chinese herbal medicine therapy on asthma. Frontiers in Endocrinology. 13. 916328–916328. 3 indexed citations

13.

Meng, Shengxi, et al.. (2022). Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment. Frontiers in Endocrinology. 13. 955618–955618. 16 indexed citations

14.

Meng, Shengxi, et al.. (2022). Tetramethylpyrazine ameliorates systemic streptozotocin-induced Alzheimer-like pathology. Journal of Chemical Neuroanatomy. 127. 102207–102207. 9 indexed citations

15.

Zhang, Qiang, Li Zhang, Kai‐Li Liu, et al.. (2022). A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease. Evidence-based Complementary and Alternative Medicine. 2022. 1–18. 9 indexed citations

16.

Meng, Shengxi, et al.. (2021). The Roles of Tetramethylpyrazine During Neurodegenerative Disease. Neurotoxicity Research. 39(5). 1665–1677. 26 indexed citations

17.

Meng, Shengxi, et al.. (2021). LncRNA MALAT1 improves cerebral ischemia-reperfusion injury and cognitive dysfunction by regulating miR-142-3p/SIRT1 axis. International Journal of Neuroscience. 133(7). 740–753. 23 indexed citations

18.

Meng, Shengxi, et al.. (2015). Rac1 contributes to cerebral ischemia reperfusion-induced injury in mice by regulation of Notch2. Neuroscience. 306. 100–114. 24 indexed citations

19.

Feng, Qin, Shengxi Meng, Cheng Huang, et al.. (2013). Qushi Huayu Decoction Inhibits Hepatic Lipid Accumulation by Activating AMP-Activated Protein KinaseIn VivoandIn Vitro. Evidence-based Complementary and Alternative Medicine. 2013. 1–14. 33 indexed citations

20.

Manning, R. Davis, Shengxi Meng, & Niu Tian. (2003). Renal and vascular oxidative stress and salt‐sensitivity of arterial pressure. Acta Physiologica Scandinavica. 179(3). 243–250. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact